Citation Impact
Citing Papers
Impairment of neutrophil extracellular trap degradation is associated with lupus nephritis
2010 Standout
Complement Factor H Polymorphism and Age-Related Macular Degeneration
2005 StandoutScience
Effect of C1 Inhibitor on Inflammatory and Physiologic Response Patterns in Primates Suffering from Lethal Septic Shock
1998
Autoimmune Th17 Cells Induced Synovial Stromal and Innate Lymphoid Cell Secretion of the Cytokine GM-CSF to Initiate and Augment Autoimmune Arthritis
2018 StandoutNobel
Neutrophil activation on biological surfaces. Massive secretion of hydrogen peroxide in response to products of macrophages and lymphocytes.
1987
Leukotrienes and Other Products of the 5-Lipoxygenase Pathway
1990
Kinetics of Neutrophils in Mice Exposed to Radiation and/or Granulocyte Colony-Stimulating Factor Treatment
2013
New Developments in Diagnosis and Treatment of Infection in Orthopedic Implants
2001
Tissue Destruction by Neutrophils
1989 Standout
Regulation and termination of NADPH oxidase activity
2005
Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance
2003 Standout
Inflammation and insulin resistance
2006 Standout
The NOX Family of ROS-Generating NADPH Oxidases: Physiology and Pathophysiology
2007 Standout
Interleukin-17 and Type 17 Helper T Cells
2009 Standout
Broad-Spectrum Antibiotic or G-CSF as Potential Countermeasures for Impaired Control of Bacterial Infection Associated with an SPE Exposure during Spaceflight
2015 StandoutNobel
2 Inhibitors of Human Leukocyte Elastase
1994
SLAM Family Receptors Distinguish Hematopoietic Stem and Progenitor Cells and Reveal Endothelial Niches for Stem Cells
2005 Standout
HIF-1α Is Essential for Myeloid Cell-Mediated Inflammation
2003 Standout
Photodynamic therapy and anti-tumour immunity
2006 Standout
Hindlimb Suspension and SPE-Like Radiation Impairs Clearance of Bacterial Infections
2014 StandoutNobel
Interleukin-6 and interleukin-8 protein and gene expression in human arterial atherosclerotic wall
1996
The Classical Complement Cascade Mediates CNS Synapse Elimination
2007 Standout
Regulation and proinflammatory properties of the chemotactic protein CP-10
1996
Free radicals and antioxidants in normal physiological functions and human disease
2006 Standout
Virus-induced autoantibody response to a transgenic viral antigen
1990 StandoutNatureNobel
Calcium oscillations increase the efficiency and specificity of gene expression
1998 StandoutNature
Complement
2001 Standout
Complement inhibitors: a resurgent concept in anti-inflammatory therapeutics
2000
A Dominant Complement Fixation Pathway for Pneumococcal Polysaccharides Initiated by SIGN-R1 Interacting with C1q
2006 StandoutNobel
Disseminated Intravascular Coagulation
1999 Standout
Complement receptors in HIV infection
1997
Points of control in inflammation
2002 StandoutNature
Modulation of Leukocyte Behavior by an InflamedExtracellular Matrix
2000
The internal thioester and the covalent binding properties of the complement proteins C3 and C4
1997
Localization of the binding site for the human high-affinity Fc receptor on IgG
1988 StandoutNatureNobel
The binding site for C1q on IgG
1988 StandoutNatureNobel
Oxidative cross-linking of immune complexes by human polymorphonuclear leukocytes.
1988
Treatment of Infections Associated with Surgical Implants
2004 Standout
RAGE Mediates a Novel Proinflammatory Axis
1999 Standout
Integrins: A family of cell surface receptors
1987 Standout
T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines.
1996
The leukotriene B4 paradox: neutrophils can, but will not, respond to ligand-receptor interactions by forming leukotriene B4 or its ω-metabolites
1987
β-Arrestin inhibits NF-κB activity by means of its interaction with the NF-κB inhibitor IκBα
2004 StandoutNobel
Molecular Recognition of Protein−Ligand Complexes: Applications to Drug Design
1997 Standout
Molecular Biology and Chemistry of the Alternative Pathway of Complement
1980
Photoexpulsion of Surface-Grafted Ruthenium Complexes and Subsequent Release of Cytotoxic Cargos to Cancer Cells from Mesoporous Silica Nanoparticles
2013 StandoutNobel
Regulation of nuclear factor kappaB activation by G-protein-coupled receptors.
2001
Expression of murine interleukin 7 in a murine glioma cell line results in reduced tumorigenicity in vivo.
1992 StandoutNobel
Leukocyte lipid body formation and eicosanoid generation: cyclooxygenase-independent inhibition by aspirin.
1996 StandoutNobel
Serpin Structure, Mechanism, and Function
2002 Standout
Sequence determination of the thiolester site of the fourth component of human complement.
1981
Human complement component C4. Structural studies on the fragments derived from C4b by cleavage with C3b inactivator
1981
Immunoglobulin G: Functional sites
1985
Pro-Carboxypeptidase R is an Acute Phase Protein in the Mouse, Whereas Carboxypeptidase N Is Not
2000 StandoutNobel
Human complement component C3: cDNA coding sequence and derived primary structure.
1985
Proteolytic cleavage and inactivation of alpha 2-plasmin inhibitor and C1 inactivator by human polymorphonuclear leukocyte elastase.
1982
Granulocyte colony-stimulating factor gene transfer suppresses tumorigenicity of a murine adenocarcinoma in vivo.
1991
Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity.
1993 Standout
Surface-Enhanced Raman Spectroscopy for Bioanalysis: Reliability and Challenges
2018 Standout
Macrophages secrete a novel heparin-binding protein with inflammatory and neutrophil chemokinetic properties.
1988 StandoutNobel
Common evolutionary origin of alpha 2-macroglobulin and complement components C3 and C4.
1985
Dysfunctional C1-inhibitor(At), isolated from a type II hereditary-angio-oedema plasma, contains a P1 ‘reactive centre’ (Arg444→His) mutation
1988
Functional Nanomaterials for Phototherapies of Cancer
2014 Standout
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
Biological activities of complement-derived peptides
1987
Glycobiology: Toward Understanding the Function of Sugars
1996 Standout
Biologic activity of cytotoxic T lymphocyte-associated antigen 4 antibody blockade in previously vaccinated metastatic melanoma and ovarian carcinoma patients
2003 StandoutNobel
Interleukin-8 induces rapid mobilization of hematopoietic stem cells with radioprotective capacity and long-term myelolymphoid repopulating ability
1995
Neutrophils degrade subendothelial matrices in the presence of alpha-1-proteinase inhibitor. Cooperative use of lysosomal proteinases and oxygen metabolites.
1984
Effector functions of a monoclonal aglycosylated mouse IgG2a: Binding and activation of complement component C1 and interaction with human monocyte Fc receptor
1985
Albumin inhibits neutrophil spreading and hydrogen peroxide release by blocking the shedding of CD43 (sialophorin, leukosialin)
1993
Chemistry of Biologically Important Synthetic Organoselenium Compounds
2001 Standout
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Activatable Photosensitizers for Imaging and Therapy
2010 Standout
Regulation of nuclear factor κB activation by G-protein-coupled receptors
2001
Imaging and Photodynamic Therapy: Mechanisms, Monitoring, and Optimization
2010 Standout
Ionizing Radiation Selectively Reduces Skin Regulatory T Cells and Alters Immune Function
2014 StandoutNobel
Constitutive expression of a complement-like protein in Toll and JAK gain-of-function mutants ofDrosophila
2000 StandoutNobel
Reversible Photochemical Control of Singlet Oxygen Generation Using Diarylethene Photochromic Switches
2014 StandoutNobel
The immunogenicity of chimeric antibodies.
1989 StandoutNobel
The Biology and Detection of Immune Complexes
1980
Complete primary structure of human C4a anaphylatoxin.
1981
Thrombospondin stimulates motility of human neutrophils.
1990 StandoutNobel
Isolation of cDNA clones specifying the fourth component of mouse complement and its isotype, sex-limited protein.
1984 StandoutNobel
The interleukin-8 AP-1 and kappa B-like sites are genetic end targets of FK506-sensitive pathway accompanied by calcium mobilization.
1994
Third component of human complement: Localization of the internal thiolester bond
1982
Works of T E Hugli being referenced
Characterization of Receptors to the Anaphylatoxins on Isolated Cells
1989
Chemotaxis
1989
C5a-mediated release of interleukin 6 by human monocytes
1990
Leukotriene C4 production by murine mast cells: evidence of a role for extracellular leukotriene A4.
1985
Characterization of human C4a anaphylatoxin.
1981
C4a: the third anaphylatoxin of the human complement system.
1979
Role of cell surface contact in the kinetics of superoxide production by granulocytes.
1983
Heat-induced fragmentation of human alpha 2-macroglobulin.
1979
Limited degradation of the third component (C3) of human complement by human leukocyte elastase (HLE): partial characterization of C3 fragments
1977
Isolation and identification of a biologically active peptide derived from the CH3 domain of human IgG1.
1982
Studies on human plasma C1 inactivator-enzyme interactions. II. Structural features of an abnormal C1 inactivator from a kindred with hereditary angioneurotic edema.
1975
Neutrophil chemotactic factors promote leukocytosis. A common mechanism for cellular recruitment from bone marrow.
1992
C5a-induced neutrophilia. A primary humoral mechanism for recruitment of neutrophils.
1990